336 related articles for article (PubMed ID: 28652246)
1. MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy.
Reinhardt J; Landsberg J; Schmid-Burgk JL; Ramis BB; Bald T; Glodde N; Lopez-Ramos D; Young A; Ngiow SF; Nettersheim D; Schorle H; Quast T; Kolanus W; Schadendorf D; Long GV; Madore J; Scolyer RA; Ribas A; Smyth MJ; Tumeh PC; Tüting T; Hölzel M
Cancer Res; 2017 Sep; 77(17):4697-4709. PubMed ID: 28652246
[TBL] [Abstract][Full Text] [Related]
2. Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.
Young A; Ngiow SF; Madore J; Reinhardt J; Landsberg J; Chitsazan A; Rautela J; Bald T; Barkauskas DS; Ahern E; Huntington ND; Schadendorf D; Long GV; Boyle GM; Hölzel M; Scolyer RA; Smyth MJ
Cancer Res; 2017 Sep; 77(17):4684-4696. PubMed ID: 28652244
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.
Gao Z; Wang L; Song Z; Ren M; Yang Y; Li J; Shen K; Li Y; Ding Y; Yang Y; Zhou Y; Wei C; Gu J
Front Immunol; 2022; 13():954039. PubMed ID: 36131912
[TBL] [Abstract][Full Text] [Related]
4. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy induces enrichment of CD47
Samanta D; Park Y; Ni X; Li H; Zahnow CA; Gabrielson E; Pan F; Semenza GL
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1239-E1248. PubMed ID: 29367423
[TBL] [Abstract][Full Text] [Related]
6. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
[TBL] [Abstract][Full Text] [Related]
7. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
8. Autocrine Adenosine Regulates Tumor Polyfunctional CD73
Gourdin N; Bossennec M; Rodriguez C; Vigano S; Machon C; Jandus C; Bauché D; Faget J; Durand I; Chopin N; Tredan O; Marie JC; Dubois B; Guitton J; Romero P; Caux C; Ménétrier-Caux C
Cancer Res; 2018 Jul; 78(13):3604-3618. PubMed ID: 29559470
[TBL] [Abstract][Full Text] [Related]
9. The potential role of adenosine signaling in the pathogenesis of melanoma.
Bahreyni A; Rezaei M; Khazaei M; Fuiji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
Biochem Pharmacol; 2018 Oct; 156():451-457. PubMed ID: 30232037
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
Morello S; Capone M; Sorrentino C; Giannarelli D; Madonna G; Mallardo D; Grimaldi AM; Pinto A; Ascierto PA
J Transl Med; 2017 Dec; 15(1):244. PubMed ID: 29202855
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma.
Soleimani A; Farshchi HK; Mirzavi F; Zamani P; Ghaderi A; Amini Y; Khorrami S; Mashayekhi K; Jaafari MR
Biochimie; 2020 Sep; 176():21-30. PubMed ID: 32585229
[TBL] [Abstract][Full Text] [Related]
12. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
[TBL] [Abstract][Full Text] [Related]
13. Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis.
Botta Gordon-Smith S; Ursu S; Eaton S; Moncrieffe H; Wedderburn LR
Arthritis Rheumatol; 2015 Feb; 67(2):545-54. PubMed ID: 25418634
[TBL] [Abstract][Full Text] [Related]
14. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
[TBL] [Abstract][Full Text] [Related]
15. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target.
Yang J; Liao X; Yu J; Zhou P
Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574
[TBL] [Abstract][Full Text] [Related]
16. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
17. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
Quast C; Alter C; Ding Z; Borg N; Schrader J
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
[TBL] [Abstract][Full Text] [Related]
18. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R; Capone M; Giannarelli D; Morretta E; Monti MC; Madonna G; Mallardo D; Festino L; Azzaro R; Levesque MP; Imhof L; Weide B; Amaral T; Chevrier M; Sucker A; Rutkowski P; Schadendorf D; Lebbe C; Luke JJ; Wistuba-Hamprecht K; Dummer R; Pinto A; Morello S; Ascierto PA
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361405
[TBL] [Abstract][Full Text] [Related]
19. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses.
Chen X; Shao H; Zhi Y; Xiao Q; Su C; Dong L; Liu X; Li X; Zhang X
Stem Cells Dev; 2016 Feb; 25(4):337-46. PubMed ID: 26650818
[TBL] [Abstract][Full Text] [Related]
20. CD73 Activity is Dispensable for the Polarization of M2 Macrophages.
Eichin D; Laurila JP; Jalkanen S; Salmi M
PLoS One; 2015; 10(8):e0134721. PubMed ID: 26258883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]